Showing results (1111-1120 of 1,376) with videos related to
Sort By:
Pageof 138
Biorxiv : the Preprint Server for Biology|September 30, 2024
Cholesterol binding to VCAM-1 promotes vascular inflammationJohn P Kennelly, Xu Xiao, Yajing Gao, et al.Journal of Medicinal Chemistry|January 12, 2016
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 InhibitorsGuanglin Luo, Ling Chen, Catherine R Burton, et al.Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS TrialJ H Alexander, H Yang, R C Becker, et al.Journal of Virology|August 7, 2015
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in SpecificityJoyce K Hu, Jordan C Crampton, Albert Cupo, et al.Science Advances|November 27, 2018
HIV-1 vaccine design through minimizing envelope metastabilityLinling He, Sonu Kumar, Joel D Allen, et al.Mabs|August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CAJames W Larrick, Mark R Alfenito, Jamie K Scott, et al.Communications Biology|April 12, 2022
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunitNicholas K Hurlburt, Leah J Homad, Irika Sinha, et al.Science (New York, N.Y.)|March 30, 2013
Rational HIV immunogen design to target specific germline B cell receptorsJoseph Jardine, Jean-Philippe Julien, Sergey Menis, et al.Elife|January 17, 2019
Reprogramming the antigen specificity of B cells using genome-editing technologiesJames E Voss, Alicia Gonzalez-Martin, Raiees Andrabi, et al.Science (New York, N.Y.)|September 10, 2016
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic miceDevin Sok, Bryan Briney, Joseph G Jardine, et al.Pageof 138